Does stage-3 chronic kidney disease matter? A systematic literature review

British Journal of General Practice

Volumn 60, Issue 575, 2010, Pages

  Sharma, Pawana ^a   McCullough, Keith ^a   Scotland, Graham ^c   McNamee, Paul ^c   Prescott, Gordon ^a   MacLeod, Alison ^a   Fluck, Nick ^d   Smith, William Cairns ^b   Black, Corri ^c  

^a Department of Medicine and Pharmacology ^*

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Chronic kidney disease; Natural history; Primary care; Systematic review

Indexed keywords

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC REVIEW;

EID: 78650494587     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X502173     Document Type: Review

References (44)

1. Cirillo M, Laurenzi M, Mancini M, et al. Low glomerular filtration in the population: prevalence, associated disorders, and awareness, Kidney Int 2006; 70: 800-806.
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
3. McCullough K, Wannamethee G, Tunstall-Pedoe H, et al. High prevalence of CKD in the Middle-aged UK population: the Scottish Heart Health Study and the British Regional Heart Study (poster). Stockholm: XLV ERA-EDTA Congress, 10-13 May 2008.
4. Nitsch D, Felber Dietrich D, Von Eckardstein A, et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21: 935-944.
5. Otero A, Gayoso P, Garcia F, de Francisco AL, EPIRCE study group. Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int Suppl 2005; 99: S16-S19.
6. Viktorsdottir O, Palsson R, Andresdottir MB, et al. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 2005; 20: 1799-1807. (Pubitemid 41222591)
7. Ali T, Black C, Prescott G, et al. Preventing end stage renal disease: informing the development of a public health strategy. Edinburgh: Chief Scientist Office, 2007. http://www.sehd.scot.nhs.uk/cso/ Publications/ExecSumms/ OctNov07/Ali.pdf (accessed 11 Apr 2010).
8. Levey AS, Andreoli SP, DuBose T, et al. Chronic kidney disease: common, harmful and treatable -World Kidney Day 2007. Am J Nephrol 2007; 27: 108-112. (Pubitemid 46364548)
9. Levin A, The advantage of a uniform terminology and staging system for chronic kidney disease (CKD). Nephrol Dial Transplant 2003; 18: 1446-1451.
10. Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis 2006; 3: A57.
11. Saydah S, Eberhardt M, Rios-Burrows N, et al. Prevalence of chronic kidney disease and associated risk factors - United States, 19992004. JAMA 2007; 297: 1767-1768.
12. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
13. UK and Scottish Renal Associations. Consensus statement on management of early CKD, February 2007. Edinburgh: Royal College of Physicians of Edinburgh, 2007. http://www.renal.org/CKDguide/consensus.html (accessed 11 Apr 2010).
14. Lamb EJ. United Kingdom guidelines for chronic kidney disease. Scand J Clin Lab Invest Suppl 2008; 241: 16-22.
15. National Institute for Health and Clinical Excellence. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. London: NICE, 2008. http://guidance.nice.org.uk/ CG73 (accessed 11 Apr 2010).
16. Scottish Intercollegiate Guidelines Network. Diagnosis and management of chronic kidney disease. Edinburgh: SIGN, 2008. http://www.sign.ac.uk/guidelines/ fulltext/103/index.html (accessed 11 Apr 2010).
17. Heffernan C. Screening for chronic kidney disease: an evidence based review for the National Screening Committee. London: UK National Screening Committee, 2008. http://www.library.nhs.uk/screening/ ViewResource.aspx?resID= 301152 (accessed 11 Apr 2010).
18. McCullough PA, Li S, Jurkovitz CT, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S38-S45.
19. Klebe B, Irving J, Stevens PE, et al. The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant 2007; 22: 2504-2512. (Pubitemid 47365513)
20. Feehally J, Griffith KE, Lamb EJ, et al. Early detection of chronic kidney disease. BMJ 2008; 337: a1618.
21. Poggio ED, Rule AD, A critical evaluation of chronic kidney disease - should isolated reduced estimated glomerular filtration rate be considered a 'disease'? Nephrol Dial Transplant 2009; 24: 698-700.
22. Anonymous. CRD's guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination, 2008. http://www.york.ac.uk/inst/crd/pdf/ Systematic-Reviews.pdf (accessed 11 Apr 2010).
23. Anonymous. Critical Appraisal Skills Programme: making sense of evidence. 12 questions to help you make sense of a cohort study. Oxford: Public Health Resource Unit, 2008. http://www.phru.nhs.uk/Doe-Links/cohort%2012%20questions. pdf (accessed 11 Apr 2010).
24. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384. (Pubitemid 28438523)
25. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007; 36: 666-676.
26. Wells GA, Shea B, O'Connell D, et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm (accessed 10 May 2010).
27. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047-1050. (Pubitemid 44807817)
28. Hallan S, Astor B, Romundstad S, et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496.
29. Hallan SI, Ritz E, Lydersen S, et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077.
30. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663. (Pubitemid 38392981)
31. Gullion CM, Keith DS, Nichols GA, Smith DH. Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis 2006; 48: 212-220.
32. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382.
33. Eriksen BO, Ingebretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007; 72: 1242-1248.
34. Chiu YL, Chien KL, Lin SL, et al. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 2008; 109: c109-c118.
35. Djamali A, Kendziorski C, Brazy PC, Becker BN. Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int 2003; 64: 1800-1807.
36. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, New Engl J Med 2004; 351: 1296-1305.
37. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006; 69: 2155-2161.
38. Khatami Z, Handley G, Narayanan K, Weaver JU. Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease. Scand J Clin Lab Invest 2007; 67: 297-305.
39. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006; 17: 846-853.
40. Orlando LA, Owen WF, Matchar DB, Relationship between nephrologist care and progression of chronic kidney disease. N C Med J 2007; 68: 9-16.
41. Brantsma AH, Bakker SJ, Hillege HL, et al. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008; 23: 3851-3858.
42. Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10ycar follow-up study. Hypertens Res 2008; 31: 433-441.
43. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182.
44. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-Converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73-87.